| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |